학술논문

Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial
Document Type
Article
Source
In: Oncologist. (Oncologist, March 2024, 29(3):254-262)
Subject
Language
English
ISSN
1549490X
10837159